Eugene M. Berkman

1.1k total citations
21 papers, 758 citations indexed

About

Eugene M. Berkman is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Eugene M. Berkman has authored 21 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 6 papers in Immunology and 4 papers in Genetics. Recurrent topics in Eugene M. Berkman's work include Blood groups and transfusion (6 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Platelet Disorders and Treatments (3 papers). Eugene M. Berkman is often cited by papers focused on Blood groups and transfusion (6 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Platelet Disorders and Treatments (3 papers). Eugene M. Berkman collaborates with scholars based in United States. Eugene M. Berkman's co-authors include Michael B. Atkins, James W. Mier, Michael M. Kaplan, David Parkinson, Kenneth B. Miller, David P. Schenkein, Kellie Sprague, Raymond L. Comenzo, Marie E. Malachowski and Stephen Caplan and has published in prestigious journals such as New England Journal of Medicine, Blood and The Journal of Immunology.

In The Last Decade

Eugene M. Berkman

21 papers receiving 721 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eugene M. Berkman United States 14 360 222 213 96 92 21 758
H Gerhartz Germany 12 261 0.7× 161 0.7× 217 1.0× 52 0.5× 112 1.2× 42 666
K. Quabeck Germany 11 345 1.0× 174 0.8× 119 0.6× 73 0.8× 57 0.6× 35 686
Y Bonny Canada 15 328 0.9× 200 0.9× 89 0.4× 76 0.8× 82 0.9× 34 678
Ronald L. Chard United States 17 445 1.2× 104 0.5× 185 0.9× 65 0.7× 110 1.2× 26 904
Eric M. Bonnem United States 18 344 1.0× 236 1.1× 379 1.8× 54 0.6× 149 1.6× 35 934
Robert H. Rudolph United States 17 387 1.1× 197 0.9× 263 1.2× 49 0.5× 182 2.0× 30 904
D. Kyriakou Greece 21 368 1.0× 166 0.7× 234 1.1× 131 1.4× 133 1.4× 44 872
Prentice Hg United Kingdom 14 354 1.0× 145 0.7× 177 0.8× 74 0.8× 68 0.7× 20 622
J. C. Biggs Australia 15 870 2.4× 226 1.0× 298 1.4× 57 0.6× 135 1.5× 31 1.1k
S Dahlberg United States 10 836 2.3× 287 1.3× 191 0.9× 58 0.6× 160 1.7× 12 973

Countries citing papers authored by Eugene M. Berkman

Since Specialization
Citations

This map shows the geographic impact of Eugene M. Berkman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugene M. Berkman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugene M. Berkman more than expected).

Fields of papers citing papers by Eugene M. Berkman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugene M. Berkman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugene M. Berkman. The network helps show where Eugene M. Berkman may publish in the future.

Co-authorship network of co-authors of Eugene M. Berkman

This figure shows the co-authorship network connecting the top 25 collaborators of Eugene M. Berkman. A scholar is included among the top collaborators of Eugene M. Berkman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugene M. Berkman. Eugene M. Berkman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanteti, Rajani, Claire Keating, Eugene M. Berkman, et al.. (2001). Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation. Blood. 98(7). 2059–2064. 119 indexed citations
3.
Quillen, Karen, et al.. (1995). Vascular erosion caused by a double‐lumen central venous catheter during therapeutic plasma exchange. Transfusion. 35(6). 510–512. 5 indexed citations
4.
Snydman, David R., Barbara G. Werner, H. Cody Meissner, et al.. (1995). Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates. The Pediatric Infectious Disease Journal. 14(1). 34–40. 39 indexed citations
5.
Comenzo, Raymond L., Marie E. Malachowski, Kenneth B. Miller, et al.. (1995). Large‐volume leukapheresis for collection of mononuclear cells for hematopoietic rescue in Hodgkin's disease. Transfusion. 35(1). 42–45. 28 indexed citations
6.
Comenzo, Raymond L., Marie E. Malachowski, H. Cody Meissner, David R. Fulton, & Eugene M. Berkman. (1992). Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. The Journal of Pediatrics. 120(6). 926–928. 58 indexed citations
7.
Comenzo, Raymond L., Marie E. Malachowski, Richard J. Rohrer, et al.. (1992). Anomalous ABO Phenotype in a Child after an ABO-Incompatible Liver Transplantation. New England Journal of Medicine. 326(13). 867–870. 31 indexed citations
8.
Hillyer, Christopher D., Raymond L. Comenzo, Kenneth B. Miller, et al.. (1991). Prompt engraftment using autologous peripheral blood stem cells for double autologous bone marrow rescue. American Journal of Hematology. 36(2). 152–153. 4 indexed citations
9.
Hillyer, Christopher D., et al.. (1990). EDTA-Dependent Leukoagglutination. American Journal of Clinical Pathology. 94(4). 458–461. 24 indexed citations
10.
Hillyer, Christopher D., et al.. (1990). Density gradient separation of peripheral blood stem cells: comparison of an automated cell processing device and manual methods. Transfusion. 30(9). 824–827. 8 indexed citations
11.
Atkins, Michael B., et al.. (1988). Hypothyroidism after Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells. New England Journal of Medicine. 318(24). 1557–1563. 225 indexed citations
12.
Patten, E. & Eugene M. Berkman. (1986). Therapeutic Plasmapheresis and Plasma Exchange. CRC Critical Reviews in Clinical Laboratory Sciences. 23(2). 147–175. 25 indexed citations
13.
Silberstein, Leslie E., Yehuda Shoenfeld, Robert S. Schwartz, & Eugene M. Berkman. (1985). A Combination of IgG and IgM Autoantibodies in Chronic Cold Agglutinin Disease: Immunologic Studies and Response to Splenectomy. Vox Sanguinis. 48(2). 105–109. 10 indexed citations
14.
Berkman, Eugene M. & Joel Umlas. (1980). Therapeutic hemapheresis : a technical workshop. 18 indexed citations
15.
Orlin, Jerome, Eugene M. Berkman, Daniel S. Matloff, & Marshall M. Kaplan. (1980). Primary biliary cirrhosis and cold autoimmune hemolytic anemia: Effect of partial plasma exchange. Gastroenterology. 78(3). 576–578. 15 indexed citations
16.
Raum, D, et al.. (1978). Evidence for a Silent or Null Gene in Hereditary C2 Deficiency. The Journal of Immunology. 121(6). 2580–2581. 32 indexed citations
17.
Caplan, Stephen, Eugene M. Berkman, & Bernard Babior. (1977). Cytotoxins against a Granulocyte Antigen System:Detection by a New Method EmployingCytochalasin-B-Treated Cells. Vox Sanguinis. 33(4). 206–211. 1 indexed citations
18.
Caplan, Stephen & Eugene M. Berkman. (1976). Immunosuppressive Therapy of Idiopathic Thrombocytopenic Purpura. Medical Clinics of North America. 60(5). 971–986. 21 indexed citations
19.
Nusbacher, Jacob, Eugene M. Berkman, Kwan Y. Wong, Shaul Kochwa, & Richard E. Rosenfield. (1972). Assay of IgG and Other Human Plasma Proteins by Quantitative Inhibition of Passive Hemagglutination. The Journal of Immunology. 108(4). 893–902. 10 indexed citations
20.
Rosenfield, Richard E., et al.. (1971). IMMUNOCHEMISTRY OF THE RH SYSTEM: V. DETERMINATION OF RH AGGLUTINATING ACTIVITY AND IgG CONTENT OF SEQUENTIAL ELUATES FOR THE ASSAY OF RH ANTIBODY *. Annals of the New York Academy of Sciences. 190(1). 519–528. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026